OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody
2020 · British Journal of Cancer · 85 citations
https://doi.org/10.1038/s41416-020-0810-1
H
Hisanobu Oda
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
2.1K
Citations
14
h-index
18
i10-index
Hisanobu Oda is an academic researcher from Saiseikai Kumamoto Hospital. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Pancreatic and Hepatic Oncology Research & Epigenetics and DNA Methylation. The author has an h-index of 14, co-authored 39 publications.
Papers by this author
worksInteraction of PKN with a neuron-specific basic Helix–Loop–Helix transcription factor, NDRF/NeuroD2
1999 · Molecular Brain Research · 18 citations
https://doi.org/10.1016/s0169-328x(99)00273-9
LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer
2016 · Cancer Chemotherapy and Pharmacology · 14 citations
https://doi.org/10.1007/s00280-016-3214-4
Microarray analysis of the genes induced by tetracycline-regulated expression of NDRF/NeuroD2 in P19 cells
2005 · Biochemical and Biophysical Research Communications · 12 citations
https://doi.org/10.1016/j.bbrc.2005.07.093
Structure of the mouse NDRF gene and its regulation during neuronal differentiation of P19 cells
2000 · Molecular Brain Research · 9 citations
https://doi.org/10.1016/s0169-328x(00)00038-3
Histone methyltransferase Setd8 preserves chromatin accessibility to safeguard retinal progenitor cell identity during development
2026 · Stem Cell Reports · 0 citations
https://doi.org/10.1016/j.stemcr.2025.102789
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat